Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia

October 2026

Cough, cold and allergy (hay fever) remedies in Saudi Arabia has demonstrated a rebound to growth in 2026, expected to post a retail value of SAR1,322 million, driven by unique local factors such as persistent dust storms, high pollen levels, and the influx of millions of pilgrims alongside the 36.7 million population. This environment, combined with a contained inflation rate of 2% and low GDP growth, has supported strong consumer demand, making this area attractive for both established brands and new entrants seeking growth opportunities. Competitive intensity has sharpened, with leading pharmacy chains expanding their digital ecosystems, private label ranges, and exclusive product lines, while rapid advances in e-commerce and quick delivery platforms are reshaping how consumers access respiratory treatments, particularly during seasonal peaks. Success now hinges on strategies that align with the digital transformation of retail, investment in pharmacy partnerships, and a focus on differentiated offerings that address both acute and chronic respiratory needs, with trusted pharmacy guidance and rapid availability remaining decisive factors for sustained growth.

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Saudi Arabia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Saudi Arabia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia?
  • Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia?
  • How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia?
  • How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in Saudi Arabia?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Key Data Insights

Key Industry Trends

A return to growth as environmental and seasonal drivers drive demand
Cough remedies leads sales, while antihistamines and paediatric products reinforce breadth
Digital expansion and pharmacy consolidation reshape consumer access
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Cough remedies to sustain lead while medicated confectionery to drive growth
E-pharmacies and quick delivery to reshape consumer expectations
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Spimaco strengthens its lead with portfolio depth and pharmacy reach
Pharmacy-exclusive brands and private label fuel new growth
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies leverage trust and expansion to sustain leadership
Digital and quick commerce channels reshape consumer access and competition
Chart 1 Retail Channels 2021-2026
Pharmacy chains build integrated healthcare ecosystems
Exclusive brands and private label lines widen the product offer
Competitive dynamics shift as retailer power grows
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031

Country Reports Disclaimer

The following categories and subcategories are included:

Cough, Cold and Allergy (Hay Fever) Remedies

  • Antihistamines/Allergy Remedies (Systemic)
    • Paediatric Allergy Remedies
    • Paediatric Cough/Cold Remedies
  • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
  • Cough Remedies
    • Nasal Sprays
    • Oral Decongestants
    • Inhalant Decongestants
    • Decongestant Rubs
    • Nasal Decongestant Drops
    • Nasal Decongestant Plasters
  • Medicated Confectionery
  • Pharyngeal Preparations

Cough, Cold and Allergy (Hay Fever) Remedies

This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!